Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
345.00
+12.00 (3.60%)
Aug 6, 2026, 3:10 PM JST

Kringle Pharma Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
73728069391289
Revenue Growth
1.39%-10.00%15.94%-82.35%35.29%-38.12%
Gross Profit
73728069303218
Operating Income
-913-909-817-889-426-358
Net Income
-920-916-756-854-331-301
Earnings Per Share
-130.47-133.88-118.14-158.44-68.16-72.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Cash (Debt)
1,5881,6192,3132,1362,7562,137
Net Cash Growth
-15.80%-30.00%8.29%-22.50%28.97%1.67%
Net Cash Per Share
225.20236.63361.45396.27567.55514.49
Cash & Investments
1,5881,6192,3132,1362,7562,137

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-520-755-661-68915-560
Free Cash Flow
-520-755-661-68915-560
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
100.00%100.00%100.00%100.00%77.49%75.43%
Operating Margin
-1250.68%-1262.50%-1021.25%-1288.41%-108.95%-123.88%
Pretax Margin
-1257.53%-1270.83%-943.75%-1236.23%-84.40%-103.81%
Profit Margin
-1260.27%-1272.22%-945.00%-1237.68%-84.66%-104.15%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
33.7343.8772.0062.586.1913.56